Characteristics, management and outcome of acquired amegakaryocytic thrombocytopenia
- PMID: 35538740
- DOI: 10.1111/bjh.18235
Characteristics, management and outcome of acquired amegakaryocytic thrombocytopenia
Similar articles
-
Acquired amegakaryocytic thrombocytopenia previously diagnosed as idiopathic thrombocytopenic purpura in a patient with hepatitis C virus infection.World J Gastroenterol. 2017 Sep 21;23(35):6540-6545. doi: 10.3748/wjg.v23.i35.6540. World J Gastroenterol. 2017. PMID: 29085203 Free PMC article.
-
Acquired Amegakaryocytic Thrombocytopenic Purpura: A Review of Therapeutic Options.Hematol Oncol Stem Cell Ther. 2023 Apr 4;16(3):291-302. doi: 10.56875/2589-0646.1063. Hematol Oncol Stem Cell Ther. 2023. PMID: 37023223 Review.
-
Acquired amegakaryocytic thrombocytopenia after durvalumab administration.J Clin Exp Hematop. 2021 Mar 18;61(1):53-57. doi: 10.3960/jslrt.20047. Epub 2021 Jan 8. J Clin Exp Hematop. 2021. PMID: 33431742 Free PMC article.
-
Acquired amegakaryocytic thrombocytopenic purpura.Am J Hematol. 2006 Feb;81(2):132-5. doi: 10.1002/ajh.20510. Am J Hematol. 2006. PMID: 16432869
-
Rapid progression of acquired amegakaryocytic thrombocytopenia to aplastic anemia.South Med J. 1997 Jan;90(1):91-4. doi: 10.1097/00007611-199701000-00024. South Med J. 1997. PMID: 9003837 Review.
Cited by
-
Successful avatrombopag combined with cyclosporine treatment for carboplatin/pegylated liposomal doxorubicin/bevacizumab-induced acquired amegakaryocytic thrombocytopenia in a patient with recurrent ovarian cancer: case report.Front Oncol. 2024 Feb 9;14:1253230. doi: 10.3389/fonc.2024.1253230. eCollection 2024. Front Oncol. 2024. PMID: 38406810 Free PMC article.
-
Outcomes of patients undergoing allogeneic haematopoietic stem cell transplantation for congenital amegakaryocytic thrombocytopenia; a study on behalf of the PDWP of the EBMT.Bone Marrow Transplant. 2024 Dec;59(12):1717-1725. doi: 10.1038/s41409-024-02416-x. Epub 2024 Sep 18. Bone Marrow Transplant. 2024. PMID: 39289521
-
Acquired Amegakaryocytic Thrombocytopenia Associated With Autoimmune Hemolytic Anemia.Cureus. 2022 Jul 26;14(7):e27315. doi: 10.7759/cureus.27315. eCollection 2022 Jul. Cureus. 2022. PMID: 36042987 Free PMC article.
-
Immune checkpoint inhibitor-related acquired amegakaryocytosis thrombocytopenia: a case report and literature review.Front Oncol. 2024 Mar 7;14:1353896. doi: 10.3389/fonc.2024.1353896. eCollection 2024. Front Oncol. 2024. PMID: 38515568 Free PMC article.
References
REFERENCES
-
- Simkins A, Maiti A, Short NJ, Jain N, Popat U, Patel KP, et al. Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation. Hematol Oncol Stem Cell Ther. 2019;12(2):115-8.
-
- Ja K, My E, Lf L. Rapid progression of acquired amegakaryocytic thrombocytopenia to aplastic anemia. South Med J. 1997;90(1):91-4.
-
- Novotný JP, Köhler B, Max R, Egerer G. Acquired Amegakaryocytic thrombocytopenic purpura progressing into aplastic anemia. Prague Med Rep. 2017;118(4):147-55.
-
- Slater LM, Katz J, Walter B, Armentrout SA. Aplastic anemia occurring as amegakaryocytic thrombocytopenia with and without an inhibitor of granulopoiesis. Am J Hematol. 1985;18(3):251-4.
-
- Hoffman R, Bruno E, Elwell J, Mazur E, Gewirtz AM, Dekker P, et al. Acquired amegakaryocytic thrombocytopenic purpura: a syndrome of diverse etiologies. Blood. 1982;60(5):1173-8.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical